Direktorat Registrasi ObatValid

PANTOZOL IV

BPOM Number: DKI1553300844A1
Approved: 27 June 2026
Expiry: 25 March 2030
Form: SERBUK INJEKSI

About This Registration

PANTOZOL IV is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI1553300844A1. Its current registration status is Valid, with the licence valid until 25 March 2030. The product is registered to TAKEDA INDONESIA and manufactured by TAKEDA INDONESIA - INDONESIA. BPOM first approved this registration in April 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 5 July 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 1 VIAL @ 40 MG
Department: Direktorat Registrasi Obat
Data Last Updated: 5 July 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

TAKEDA INDONESIA
Kota Jakarta Selatan, DKI Jakarta, Indonesia
NPWP: 010001006052000
owner
View profile →

Manufacturing Sites

TAKEDA INDONESIA - INDONESIA
KAB. BEKASI
primary
View profile →

Ingredients (1)

PANTOPRAZOLE SODIUM SESQUIHYDRATE

Market Intelligence

Owner Portfolio: TAKEDA INDONESIA holds 46 BPOM registrations
Manufacturer Scale: TAKEDA INDONESIA - INDONESIA produces 41 registered products
Registration Age: Registered for 5 months
Update Status: Recently updated (88 days ago)